279 related articles for article (PubMed ID: 14973300)
21. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
[TBL] [Abstract][Full Text] [Related]
22. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers.
Emmons GT; Argenti R; Martin LL; Martin NE; Jensen BK
J Clin Pharmacol; 2004 Aug; 44(8):901-5. PubMed ID: 15286094
[TBL] [Abstract][Full Text] [Related]
24. Comparison of systemic exposure to nemifitide following two methods of subcutaneous administration to healthy volunteers.
Nicolau G; Feighner JP; Stout R; Hlavka J; Gutierrez M; Ciric S; Freed J
Biopharm Drug Dispos; 2005 Dec; 26(9):379-85. PubMed ID: 16130176
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies.
Zia-Amirhosseini P; Hurd DD; Salfi M; Cheah TC; Aycock J; Cesano A
Pharmacotherapy; 2007 Oct; 27(10):1353-60. PubMed ID: 17896890
[TBL] [Abstract][Full Text] [Related]
27. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH
Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
[TBL] [Abstract][Full Text] [Related]
28. Safety, tolerability, and pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects: a phase I study on single oral dose.
Yamaya H; Yoshida K; Kuritani J; Yonezawa J; Tsuda M; Shindo T; Nagayama S; Buzdar AU
J Clin Pharm Ther; 2005 Oct; 30(5):459-70. PubMed ID: 16164493
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
30. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
Mansukhani MP; Kotagal S
Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
[TBL] [Abstract][Full Text] [Related]
31. The influence of gender and food on the pharmacokinetics of sodium oxybate oral solution in healthy subjects.
Borgen LA; Okerholm R; Morrison D; Lai A
J Clin Pharmacol; 2003 Jan; 43(1):59-65. PubMed ID: 12520629
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and safety of viramidine, a prodrug of ribavirin, in healthy volunteers.
Lin CC; Philips L; Xu C; Yeh LT
J Clin Pharmacol; 2004 Mar; 44(3):265-75. PubMed ID: 14973309
[TBL] [Abstract][Full Text] [Related]
33. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
34. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
Russell IJ; Perkins AT; Michalek JE;
Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
[TBL] [Abstract][Full Text] [Related]
35. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
[TBL] [Abstract][Full Text] [Related]
37. Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects.
Wong YN; King SP; Simcoe D; Gorman S; Laughton W; McCormick GC; Grebow P
J Clin Pharmacol; 1999 Mar; 39(3):281-8. PubMed ID: 10073328
[TBL] [Abstract][Full Text] [Related]
38. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
39. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
Mamelak M; Black J; Montplaisir J; Ristanovic R
Sleep; 2004 Nov; 27(7):1327-34. PubMed ID: 15586785
[TBL] [Abstract][Full Text] [Related]
40. Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study.
Park JY; Kim KA; Park PW; Suh KH; Lee GS
Clin Ther; 2004 Dec; 26(12):2092-101. PubMed ID: 15823773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]